EMVision Medical Devices Ltd (ASX:EMV)
Australia · Delayed Price · Currency is AUD 1.640
-0.050 (-2.96%)
Jun 5, 2026, 4:10 PM AEST
EMVision Medical Devices Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 5.36 | 4.89 | 11.15 | 6.96 | 4 | 1.56 |
Other Revenue | 0.07 | 0.16 | 0.07 | 0.02 | 0.36 | 0.14 |
| 5.43 | 5.05 | 11.22 | 6.97 | 4.36 | 1.7 | |
Revenue Growth (YoY) | -32.68% | -54.97% | 60.89% | 59.92% | 156.66% | 9.50% |
Gross Profit | 5.43 | 5.05 | 11.22 | 6.97 | 4.36 | 1.7 |
Selling, General & Admin | 8.93 | 8.57 | 7.26 | 6.45 | 5.86 | 3.38 |
Research & Development | 3.94 | 4.04 | 4.7 | 2.01 | 2.33 | 2.71 |
Other Operating Expenses | 0.31 | 0.31 | 0.23 | 0.21 | 0.16 | 0.05 |
Operating Expenses | 14.97 | 13.9 | 13.48 | 10.93 | 10.47 | 10.18 |
Operating Income | -9.54 | -8.84 | -2.26 | -3.96 | -6.11 | -8.49 |
Interest Expense | -0.15 | -0.09 | -0.12 | -0.04 | -0.02 | -0.01 |
Interest & Investment Income | 0.44 | 0.58 | 0.34 | 0.12 | 0.02 | 0.05 |
EBT Excluding Unusual Items | -9.25 | -8.36 | -2.03 | -3.87 | -6.11 | -8.45 |
Other Unusual Items | - | - | - | - | - | 0.05 |
Pretax Income | -9.25 | -8.36 | -2.03 | -3.87 | -6.11 | -8.4 |
Income Tax Expense | 0.95 | 1.45 | 0.7 | - | - | - |
Net Income | -10.2 | -9.81 | -2.73 | -3.87 | -6.11 | -8.4 |
Net Income to Common | -10.2 | -9.81 | -2.73 | -3.87 | -6.11 | -8.4 |
Shares Outstanding (Basic) | 87 | 85 | 80 | 78 | 75 | 70 |
Shares Outstanding (Diluted) | 87 | 85 | 80 | 78 | 75 | 70 |
Shares Change (YoY) | 3.69% | 6.22% | 3.51% | 3.35% | 7.27% | 14.16% |
EPS (Basic) | -0.12 | -0.11 | -0.03 | -0.05 | -0.08 | -0.12 |
EPS (Diluted) | -0.12 | -0.11 | -0.03 | -0.05 | -0.08 | -0.12 |
Free Cash Flow | -9.02 | -7.89 | -6.11 | 0.65 | -3.97 | -4.62 |
Free Cash Flow Per Share | -0.10 | -0.09 | -0.08 | 0.01 | -0.05 | -0.07 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -175.75% | -175.06% | -20.12% | -56.72% | -140.05% | -499.48% |
Profit Margin | -187.97% | -194.10% | -24.33% | -55.51% | -140.11% | -494.37% |
Free Cash Flow Margin | -166.20% | -156.11% | -54.43% | 9.28% | -91.12% | -272.05% |
EBITDA | -9.4 | -8.71 | -2.09 | -3.83 | -6.03 | -8.47 |
EBITDA Margin | -173.24% | -172.44% | -18.64% | -54.90% | -138.34% | - |
D&A For EBITDA | 0.14 | 0.13 | 0.17 | 0.13 | 0.07 | 0.02 |
EBIT | -9.54 | -8.84 | -2.26 | -3.96 | -6.11 | -8.49 |
EBIT Margin | -175.75% | -175.06% | -20.12% | -56.72% | -140.05% | - |
Revenue as Reported | 5.87 | 5.63 | 11.56 | 7.09 | 4.38 | 1.8 |